NCT00354666View on ClinicalTrials.gov

Single Doses GSK159797 On Patient Safety And Lung Function In Patients With Mild To Moderate Asthma

PHASE2CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

September 30, 2004

Study Completion Date

December 31, 2004

Conditions
Pulmonary Disease, Chronic Obstructive
Interventions
DRUG

GSK159797

Sponsors

Lead Sponsor

GlaxoSmithKline
All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY